4.4 million Americans have gotten updated COVID-19 boosters
Sep 23, 2022
Public health officials expect the demand for the new booster to surge in the next few weeks.
Expiration dates on Johnson & Johnson COVID-19 vaccine extended
Jun 11, 2021
The FDA has added six weeks based on data from the company’s ongoing studies on the vaccine’s stability.
Nearly 200,000 COVID-19 home tests recalled over false positives
Oct 06, 2021
The problem with the Ellume rapid antigen tests was caused by variations in the quality of one of the raw materials used in the products.
Pfizer says new COVID-19 pill cuts severe disease by 89 percent
Nov 05, 2021
The drug is designed to prevent the coronavirus from making copies of itself.
FDA: No useful monoclonal antibody treatments left against new COVID-19 variants
Dec 05, 2022
Immunocompromised patients still can receive convalescent plasma.
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.
COVID-19 rapid test makers struggling to meet demand
Jan 21, 2022
However, the government’s order for the free test kits is in addition to existing supply and does not interfere with existing orders.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Full approval of Pfizer COVID-19 vaccine could come in September
Aug 04, 2021
The FDA said in a statement that its leaders recognized that full approval might counter vaccine hesitancy.